Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes
British Journal of Diabetes
doi 10.15277/bjd.2016.092
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2016
Authors
Publisher
ABCD Diabetes Care, Ltd.